P
CL icon

&Partners’s Colgate-Palmolive CL Stock Holding History

&Partners’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Buy
136,080
+13,904
+11% +$1.22M 0.05% 324
2026
Q1 		$10.4M Sell
122,176
-9,531
-7% -$849K 0.05% 314
2025
Q4 		$10.4M Sell
131,707
-26,863
-17% -$2.11M 0.05% 301
2025
Q3 		$12.6M Sell
158,570
-12,655
-7% -$1.08M 0.08% 230
2025
Q2 		$15.6M Buy
171,225
+40,250
+31% +$3.67M 0.12% 169
2025
Q1 		$12.2M Sell
130,975
-6,426
-5% -$575K 0.13% 154
2024
Q4 		$12.3M Buy
137,401
+39,809
+41% +$3.8M 0.15% 137
2024
Q3 		$10.1M Buy
97,592
+48,713
+100% +$4.96M 0.2% 118
2024
Q2 		$4.74M Buy
48,879
+30,994
+173% +$2.86M 0.21% 109
2024
Q1 		$1.61M Buy
17,885
+242
+1% +$20.5K 0.22% 94
2023
Q4 		$1.41M Buy
17,643
+129
+0.7% +$9.7K 0.34% 70
2023
Q3 		$1.25M Buy
17,514
+105
+0.6% +$7.85K 0.58% 33
2023
Q2 		$1.34M Buy
17,409
+97
+0.6% +$7.51K 0.6% 31
2023
Q1 		$1.3M Buy
17,312
+106
+0.6% +$7.88K 0.63% 33
2022
Q4 		$1.36M Buy
17,206
+103
+0.6% +$7.72K 0.67% 31
2022
Q3 		$1.2M Buy
+17,103
New +$1.34M 0.69% 32

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

&Partners's CL Position: Q2 2026 in Review

&Partners increased its Colgate-Palmolive (CL) stake by 11% in Q2 2026, buying an estimated $1.22M and bringing the position to 136,080 shares worth $12.5M. The position accounts for 0.05% of the portfolio, ranked #324.

&Partners first reported a position in CL in Q3 2022 and has held it in 16 quarters since. The position peaked at $15.6M in Q2 2025. 2,016 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • &Partners held 136,080 shares of Colgate-Palmolive worth $12.5M as of Q2 2026.
  • &Partners bought 13,904 Colgate-Palmolive shares in Q2 2026, an estimated $1.22M.
  • Colgate-Palmolive made up 0.05% of &Partners's portfolio in Q2 2026, its #324 holding.
  • &Partners first reported a position in Colgate-Palmolive in Q3 2022 and has held it in 16 quarters since.
  • &Partners's Colgate-Palmolive position peaked at $15.6M in Q2 2025.
  • 2,016 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.